Brivanib (B) in Advanced Ovarian Cancer (OC): Subset Results of a Phase 2 Randomized Discontinuation Trial (RDT)

Kaye, S.B.; Siu, L.L.; Jassem, J.; Medioni, J; Soetekouw, P.M.M.B.; Slater, S; Rudin, C.M.; Schwartz, G.K.; de Jonge, M.; O'Dwyer, P.; Baudelet, C; CHEN, A; Ratain, M.J.

doi:10.1093/annonc/mds401

Record: found
Abstract: not found
Article: not found

Brivanib (B) in Advanced Ovarian Cancer (OC): Subset Results of a Phase 2 Randomized Discontinuation Trial (RDT)

Author(s): S.B. Kaye , L.L. Siu , J. Jassem , J. Medioni , P.M.M.B. Soetekouw , S. Slater , C.M. Rudin , G.K. Schwartz , M. De Jonge , P. O'Dwyer , C. Baudelet , A. Chen , M.J. Ratain

Publication date Created: September 2012

Publication date (Print): September 2012

Journal: Annals of Oncology

Publisher: Oxford University Press (OUP)

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Annals of Oncology

Abbreviated Title: Annals of Oncology

Publisher: Oxford University Press (OUP)

ISSN (Print): 09237534

Publication date Created: September 2012

Publication date (Print): September 2012

Volume: 23

Page: ix319

Article

DOI: 10.1093/annonc/mds401

SO-VID: 73afdd64-d1ae-418c-a865-07d33f27f576

License:

https://www.elsevier.com/tdm/userlicense/1.0/

http://www.elsevier.com/open-access/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Brivanib (B) in Advanced Ovarian Cancer (OC): Subset Results of a Phase 2 Randomized Discontinuation Trial (RDT)

Read this article at

Related collections

Scientific Ocean Drilling Expedition Research Results

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 2,761